124 related articles for article (PubMed ID: 17608469)
1. Understanding false positives in reporter gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data.
Crisman TJ; Parker CN; Jenkins JL; Scheiber J; Thoma M; Kang ZB; Kim R; Bender A; Nettles JH; Davies JW; Glick M
J Chem Inf Model; 2007; 47(4):1319-27. PubMed ID: 17608469
[TBL] [Abstract][Full Text] [Related]
2. Enhanced HTS hit selection via a local hit rate analysis.
Posner BA; Xi H; Mills JE
J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
Wu Z; Liu D; Sui Y
J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
[TBL] [Abstract][Full Text] [Related]
4. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
Shun TY; Lazo JS; Sharlow ER; Johnston PA
J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
[TBL] [Abstract][Full Text] [Related]
5. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.
Zhang XD
J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904
[TBL] [Abstract][Full Text] [Related]
6. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.
Huth JR; Mendoza R; Olejniczak ET; Johnson RW; Cothron DA; Liu Y; Lerner CG; Chen J; Hajduk PJ
J Am Chem Soc; 2005 Jan; 127(1):217-24. PubMed ID: 15631471
[TBL] [Abstract][Full Text] [Related]
7. GFscore: a general nonlinear consensus scoring function for high-throughput docking.
Betzi S; Suhre K; Chétrit B; Guerlesquin F; Morelli X
J Chem Inf Model; 2006; 46(4):1704-12. PubMed ID: 16859302
[TBL] [Abstract][Full Text] [Related]
8. Hypothesis-driven screening.
Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
[TBL] [Abstract][Full Text] [Related]
9. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
Ilouga PE; Hesterkamp T
J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
[TBL] [Abstract][Full Text] [Related]
10. The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experiments.
Zhang XD; Ferrer M; Espeseth AS; Marine SD; Stec EM; Crackower MA; Holder DJ; Heyse JF; Strulovici B
J Biomol Screen; 2007 Jun; 12(4):497-509. PubMed ID: 17435171
[TBL] [Abstract][Full Text] [Related]
11. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
[TBL] [Abstract][Full Text] [Related]
12. A method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays: a statistical terminology.
Schechtman E
J Biomol Screen; 2008 Apr; 13(4):309-11. PubMed ID: 18413895
[TBL] [Abstract][Full Text] [Related]
13. False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.
Heitman LH; van Veldhoven JP; Zweemer AM; Ye K; Brussee J; IJzerman AP
J Med Chem; 2008 Aug; 51(15):4724-9. PubMed ID: 18646744
[TBL] [Abstract][Full Text] [Related]
14. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
[TBL] [Abstract][Full Text] [Related]
15. Which aspects of HTS are empirically correlated with downstream success?
Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
[TBL] [Abstract][Full Text] [Related]
16. Trade-off between false positives and false negatives in the linkage analysis of complex traits.
Todorov AA; Rao DC
Genet Epidemiol; 1997; 14(5):453-64. PubMed ID: 9358264
[TBL] [Abstract][Full Text] [Related]
17. Fast and efficient in silico 3D screening: toward maximum computational efficiency of pharmacophore-based and shape-based approaches.
Kirchmair J; Ristic S; Eder K; Markt P; Wolber G; Laggner C; Langer T
J Chem Inf Model; 2007; 47(6):2182-96. PubMed ID: 17929799
[TBL] [Abstract][Full Text] [Related]
18. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
20. Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaign.
Moberg A; Zander Balderud L; Hansson E; Boyd H
Assay Drug Dev Technol; 2014; 12(9-10):506-13. PubMed ID: 25415593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
